REG-Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
Valneva announced senior management will present at four upcoming healthcare conferences in the U.S. and Europe during October and November 2026. The fireside chats will focus on the regulatory outlook for its Pfizer-partnered Lyme disease vaccine candidate, with regulatory decisions expected within the next 12 months.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.